DK1578422T3 - Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale - Google Patents

Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale

Info

Publication number
DK1578422T3
DK1578422T3 DK03789400T DK03789400T DK1578422T3 DK 1578422 T3 DK1578422 T3 DK 1578422T3 DK 03789400 T DK03789400 T DK 03789400T DK 03789400 T DK03789400 T DK 03789400T DK 1578422 T3 DK1578422 T3 DK 1578422T3
Authority
DK
Denmark
Prior art keywords
nicotine
physically
particulate matter
chemically stable
containing particulate
Prior art date
Application number
DK03789400T
Other languages
English (en)
Inventor
Henri Hansson
Kristensen Arne
Original Assignee
Niconovum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32683718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1578422(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Niconovum Ab filed Critical Niconovum Ab
Application granted granted Critical
Publication of DK1578422T3 publication Critical patent/DK1578422T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
DK03789400T 2002-12-20 2003-12-19 Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale DK1578422T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201984 2002-12-20
US51405003P 2003-10-24 2003-10-24
PCT/EP2003/014802 WO2004056363A2 (en) 2002-12-20 2003-12-19 A physically and chemically stable nicotine-containing particulate material

Publications (1)

Publication Number Publication Date
DK1578422T3 true DK1578422T3 (da) 2007-07-02

Family

ID=32683718

Family Applications (4)

Application Number Title Priority Date Filing Date
DK07007326.7T DK1803444T3 (da) 2002-12-20 2003-12-19 Fremgangsmåde til fremstilling af et nikotinholdigt partikelformigt materiale med en krystallinsk cellulose (især mcc)
DK18203402.5T DK3473251T3 (da) 2002-12-20 2003-12-19 Nikotin-cellulose-kombination
DK07007325.9T DK1803443T3 (da) 2002-12-20 2003-12-19 Nikotinholdigt partikelformigt materiale med en krystallinsk cellulose
DK03789400T DK1578422T3 (da) 2002-12-20 2003-12-19 Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK07007326.7T DK1803444T3 (da) 2002-12-20 2003-12-19 Fremgangsmåde til fremstilling af et nikotinholdigt partikelformigt materiale med en krystallinsk cellulose (især mcc)
DK18203402.5T DK3473251T3 (da) 2002-12-20 2003-12-19 Nikotin-cellulose-kombination
DK07007325.9T DK1803443T3 (da) 2002-12-20 2003-12-19 Nikotinholdigt partikelformigt materiale med en krystallinsk cellulose

Country Status (18)

Country Link
US (2) US8741348B2 (da)
EP (4) EP3473251B1 (da)
JP (1) JP4708795B2 (da)
KR (1) KR20050096922A (da)
CN (1) CN1738621B (da)
AT (1) ATE359075T1 (da)
AU (1) AU2003293987B2 (da)
CA (1) CA2511185C (da)
CY (1) CY1106477T1 (da)
DE (1) DE60313216T2 (da)
DK (4) DK1803444T3 (da)
ES (3) ES2285233T3 (da)
FI (1) FI3473251T3 (da)
NO (2) NO346973B1 (da)
NZ (1) NZ540817A (da)
PT (1) PT1578422E (da)
SI (1) SI1578422T1 (da)
WO (1) WO2004056363A2 (da)

Families Citing this family (230)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1803444T3 (da) * 2002-12-20 2019-02-25 Niconovum Ab Fremgangsmåde til fremstilling af et nikotinholdigt partikelformigt materiale med en krystallinsk cellulose (især mcc)
SE0302947D0 (sv) * 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
PL1648421T3 (pl) 2003-07-24 2018-03-30 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
DE602004019430D1 (de) * 2003-09-08 2009-03-26 Mcneil Ab Nikotinformulierungen und ihre verwendung
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
ES2334681T3 (es) * 2004-03-19 2010-03-15 Mcneil Ab Medios para la administracion transdermica de nicotina.
EP1761243B1 (en) 2004-06-29 2009-07-15 Fertin Pharma A/S Tobacco alkaloid releasing chewing gum
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
CA2589489C (en) 2004-11-30 2014-04-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
ATE446023T1 (de) 2005-04-29 2009-11-15 Philip Morris Prod Tabakbeutelprodukt
US9044049B2 (en) 2005-04-29 2015-06-02 Philip Morris Usa Inc. Tobacco pouch product
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US9675109B2 (en) 2005-07-19 2017-06-13 J. T. International Sa Method and system for vaporization of a substance
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US8685478B2 (en) 2005-11-21 2014-04-01 Philip Morris Usa Inc. Flavor pouch
WO2007104573A2 (en) * 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
EP1998754A2 (en) * 2006-03-16 2008-12-10 NicoNovum AB Stable lozenge compositions providing rapid release of nicotine
US7766019B2 (en) * 2006-07-21 2010-08-03 Gp Technologies, Inc. Porous plastic smoking cessation devices
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
PL2792750T3 (pl) * 2006-09-13 2020-02-28 22Nd Century Limited, Llc Zwiększanie poziomów alkaloidów nikotynowych
JP2010504931A (ja) * 2006-09-27 2010-02-18 ニコノヴァム エービー 指向性の使用
JP2008120771A (ja) * 2006-11-08 2008-05-29 Bhn Kk 便秘改善剤
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US8616221B2 (en) 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US20080210249A1 (en) * 2007-03-02 2008-09-04 Luzenberg Robert S Systems, devices and methods for delivering one or more additives to smokeless tobacco
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20090032040A1 (en) * 2007-03-30 2009-02-05 Luzenberg Jr Robert S Porous plastic smokeless tobacco substitutes
ES2521494T3 (es) * 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
GB0709162D0 (en) * 2007-05-11 2007-06-20 Jagotec Ag Dosage foam
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
WO2009010878A2 (en) 2007-07-16 2009-01-22 Philip Morris Products S.A. Method of flavor encapsulation of oral pouch products through the use of a drum coater
WO2009010876A2 (en) 2007-07-16 2009-01-22 Philip Morris Products S.A. Oral pouch product having soft edge and method of making
WO2009010881A2 (en) * 2007-07-16 2009-01-22 Philip Morris Products S.A. Oral pouch products with immobilized flavorant particles
US8202589B2 (en) * 2007-07-16 2012-06-19 Philip Morris Usa Inc. Oral delivery pouch product with coated seam
WO2009010884A2 (en) 2007-07-16 2009-01-22 Philip Morris Products S.A. Tobacco-free oral flavor delivery pouch product
WO2009037319A2 (en) * 2007-09-18 2009-03-26 Niconovum Ab Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
EP2085077A1 (en) * 2008-01-30 2009-08-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Coating compositions for controlled relaease formulations
CL2009001025A1 (es) * 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
ES2401912T3 (es) 2008-09-17 2013-04-25 Siegfried Ltd. Granulado que contiene nicotina
US8377215B2 (en) 2008-12-18 2013-02-19 Philip Morris Usa Inc. Moist botanical pouch processing
US8863755B2 (en) 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
US8747562B2 (en) 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
US20110268809A1 (en) * 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
UA112974C2 (uk) * 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
SE535587C2 (sv) * 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) * 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
CN102754907B (zh) 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
CN103040090B (zh) 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
ES2592427T3 (es) 2012-01-20 2016-11-30 Altria Client Services Inc. Producto oral
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
FR2987561B1 (fr) * 2012-03-02 2014-04-11 Pf Medicament Dispositif transdermique comprenant des micro-particules poreuses
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9339058B2 (en) 2012-04-19 2016-05-17 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
KR20230013165A (ko) 2013-05-06 2023-01-26 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
AR096223A1 (es) * 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
CN111642812A (zh) 2013-06-14 2020-09-11 尤尔实验室有限公司 电子汽化设备中的具有单独的可汽化材料的多个加热元件
CN105530916B (zh) 2013-07-11 2020-04-07 艾利斯达医药品公司 与间水杨酸形成的烟碱盐
US9521864B2 (en) 2013-07-19 2016-12-20 Altria Client Services Llc Methods and systems for incorporating nicotine into oral products
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
AU2014357622B2 (en) 2013-12-05 2019-10-24 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US9549573B2 (en) 2013-12-23 2017-01-24 Pax Labs, Inc. Vaporization device systems and methods
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
KR102256889B1 (ko) 2013-12-23 2021-05-31 쥴 랩스, 인크. 기화 디바이스 시스템 및 방법
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US11478021B2 (en) 2014-05-16 2022-10-25 Juul Labs, Inc. Systems and methods for aerosolizing a vaporizable material
US20150335070A1 (en) 2014-05-20 2015-11-26 R.J. Reynolds Tobacco Company Electrically-powered aerosol delivery system
US11019840B2 (en) 2014-07-02 2021-06-01 R.J. Reynolds Tobacco Company Oral pouch products
US10959456B2 (en) 2014-09-12 2021-03-30 R.J. Reynolds Tobacco Company Nonwoven pouch comprising heat sealable binder fiber
US20160157515A1 (en) 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
KR102627987B1 (ko) 2014-12-05 2024-01-22 쥴 랩스, 인크. 교정된 투여량 제어
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US10154689B2 (en) 2015-06-30 2018-12-18 R.J. Reynolds Tobacco Company Heat generation segment for an aerosol-generation system of a smoking article
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
CA3000770A1 (en) * 2015-10-07 2017-04-13 Fertin Pharma A/S Chewing gum comprising nicotine
EP4292454A3 (en) 2015-11-24 2024-01-17 R.J. Reynolds Tobacco Company Electrically-powered aerosol delivery system
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US11612183B2 (en) 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
EP3419443A4 (en) 2016-02-11 2019-11-20 Juul Labs, Inc. SAFE MOUNTING OF CARTRIDGES FOR EVAPORATOR DEVICES
DE202017007467U1 (de) 2016-02-11 2021-12-08 Juul Labs, Inc. Befüllbare Verdampferkartusche
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
US10329068B2 (en) 2016-05-23 2019-06-25 R.J. Reynolds Tobacco Company Flavoring mechanism for a tobacco related material
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
US10617151B2 (en) 2016-07-21 2020-04-14 Rai Strategic Holdings, Inc. Aerosol delivery device with a liquid transport element comprising a porous monolith and related method
US10602775B2 (en) 2016-07-21 2020-03-31 Rai Strategic Holdings, Inc. Aerosol delivery device with a unitary reservoir and liquid transport element comprising a porous monolith and related method
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
US10080387B2 (en) 2016-09-23 2018-09-25 Rai Strategic Holdings, Inc. Aerosol delivery device with replaceable wick and heater assembly
US11758937B2 (en) * 2016-12-30 2023-09-19 Philip Morris Products S.A. Nicotine and cellulose containing sheet
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
GB201705693D0 (en) 2017-04-07 2017-05-24 Sensus Invest Ltd Carrier, apparatus and method
RU2754412C2 (ru) 2017-04-24 2021-09-02 Свидиш Мэтч Норт Юроп Аб Ароматизированный влажный оральный пакетированный никотиновый продукт, содержащий триглицерид
US11297876B2 (en) 2017-05-17 2022-04-12 Rai Strategic Holdings, Inc. Aerosol delivery device
SE541358C2 (en) * 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S NICOTINE POCKET
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
EP3491940A1 (en) * 2017-11-29 2019-06-05 Reemtsma Cigarettenfabriken GmbH Method of manufacturing a filling material for a pouched smokeless snus product and filling material manufactured therefrom
EP3723516A1 (en) 2017-12-15 2020-10-21 Swedish Match North Europe AB A flavoured moist oral pouched nicotine product comprising monoglyceride
US10786010B2 (en) * 2017-12-15 2020-09-29 Rai Strategic Holdings, Inc. Aerosol delivery device with multiple aerosol delivery pathways
US10555558B2 (en) 2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
CN108391853A (zh) * 2018-03-06 2018-08-14 四川三联新材料有限公司 一种嗅烟粉及其制备方法以及在加热不燃烧烟草和卷烟中的应用
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited DRUG DELIVERY METHODS AND SYSTEMS
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
SE542990C2 (en) 2019-03-18 2020-09-22 Swedish Match North Europe Ab A packaging material and an oral pouched nicotine product
US20210068446A1 (en) 2019-09-11 2021-03-11 R. J. Reynolds Tobacco Company Oral product with cellulosic flavor stabilizer
US20210068447A1 (en) 2019-09-11 2021-03-11 R. J. Reynolds Tobacco Company Pouched products with enhanced flavor stability
SE1951054A1 (en) * 2019-09-18 2021-03-19 Enorama Pharma Ab Nicotine pouch
PT3833315T (pt) 2019-10-04 2022-12-20 Schjoelin Evaggelos Um produto de bolsa de contenção adequado para aplicação numa cavidade oral
MX2022005285A (es) 2019-10-31 2022-05-24 Nicoventures Trading Ltd Producto oral y metodo de fabricacion.
LU101519B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-MethyIpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a solid substance and a tablet
US20210169788A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral product and method of manufacture
US20210169123A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US20210169126A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with salt inclusion
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
US20210169784A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Buffered oral compositions
WO2021116895A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Stimulus-responsive pouch
US20210169132A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition including gels
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
WO2021116842A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
US20210169785A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral compositions with reduced water activity
US20210169121A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Liquid oral composition
US20210169129A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Lipid-containing oral composition
WO2021116916A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with multiple flavors having different release profiles
WO2021116856A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products
MX2022007013A (es) 2019-12-09 2022-09-07 Nicoventures Trading Ltd Producto oral que comprende un canabinoide.
WO2021116881A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product in a pourous pouch comprising a fleece material
WO2021116824A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021116919A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fleece for oral product with releasable component
CA3159459A1 (en) 2019-12-09 2021-06-17 Savannah JOHNSON Layered fleece for pouched product
WO2021116852A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with dissolvable component
WO2021116825A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US20210169137A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Pouched products
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
WO2021116834A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nanoemulsion for oral use
US20210169890A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with polymeric component
US20210170031A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US20210169786A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with beet material
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
WO2021116823A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
US20210169783A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral products with controlled release
US20210169868A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral compositions with reduced water content
WO2021116854A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with active ingredient combinations
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
JP2023505352A (ja) 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 方法
US20210169138A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
MX2022006980A (es) 2019-12-09 2022-08-25 Nicoventures Trading Ltd Productos embolsados con aglutinante termosellable.
US11712059B2 (en) 2020-02-24 2023-08-01 Nicoventures Trading Limited Beaded tobacco material and related method of manufacture
SE545479C2 (en) 2020-06-03 2023-09-26 Swedish Match North Europe Ab A packaging material made of wetlaid nonwoven and a pouched product for oral use
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
GB202013491D0 (en) 2020-08-27 2020-10-14 Nicoventures Holdings Ltd Oral Product
GB202013489D0 (en) 2020-08-27 2020-10-14 Nicoventures Holdings Ltd Consumable
KR20230068413A (ko) 2020-09-11 2023-05-17 니코벤처스 트레이딩 리미티드 알지네이트-기반 기재
US20220104532A1 (en) 2020-10-07 2022-04-07 NIlCOVENTURES TRADING LIMITED Methods of making tobacco-free substrates for aerosol delivery devices
CN112220756B (zh) * 2020-10-16 2023-06-13 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法
WO2022094916A1 (zh) * 2020-11-06 2022-05-12 中国科学院深圳先进技术研究院 一种提高烟酰胺磷酸核糖转移酶活性的方法及其组合物
CN114432309A (zh) * 2020-11-06 2022-05-06 中国科学院深圳先进技术研究院 一种提高烟酰胺磷酸核糖转移酶活性的方法及其组合物
US20240008522A1 (en) 2020-11-18 2024-01-11 Nicoventures Trading Limited Oral products
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
WO2022162558A1 (en) 2021-01-28 2022-08-04 Nicoventures Trading Limited Method for sealing pouches
WO2022189977A1 (en) 2021-03-09 2022-09-15 Nicoventures Trading Limited Oral products and methods of manufacture
AU2022238034A1 (en) 2021-03-19 2023-10-12 Nicoventures Trading Limited Extruded substrates for aerosol delivery devices
KR20230159852A (ko) 2021-03-19 2023-11-22 니코벤처스 트레이딩 리미티드 에어로졸 전달 장치를 위한 비드-포함 기재
JP2024516807A (ja) 2021-04-22 2024-04-17 ニコベンチャーズ トレーディング リミテッド 口腔で溶解するフィルム
WO2022224197A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition
US20220354155A1 (en) 2021-04-30 2022-11-10 Nicoventures Trading Limited Multi-compartment oral pouched product
EP4329522A1 (en) 2021-04-30 2024-03-06 Nicoventures Trading Limited Oral products with high-density load
EP4094593A1 (en) 2021-05-28 2022-11-30 Swedish Match North Europe AB A flavoured moist oral pouched nicotine product comprising ethyl cellulose
EP4355121A1 (en) 2021-06-16 2024-04-24 Nicoventures Trading Limited Pouched product comprising dissolvable composition
WO2022269475A1 (en) 2021-06-21 2022-12-29 Nicoventures Trading Limited Oral product tablet and method of manufacture
WO2022269556A1 (en) 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture
CA3225070A1 (en) 2021-07-09 2023-01-12 Caroline W. H. CLARK Extruded structures
US20230033276A1 (en) 2021-07-22 2023-02-02 Nicoventures Trading Limited Active ingredient-containing nanoemulsions
CA3224624A1 (en) 2021-07-22 2023-01-26 Steven Alderman Composition comprising a constituent, derivative or extract of cannabis
AU2022315022A1 (en) 2021-07-22 2024-01-18 Nicoventures Trading Limited Compositions comprising constituents, derivatives or extracts of cannabis
IL309993A (en) 2021-07-22 2024-03-01 Nicoventures Trading Ltd A component, derivative or extract of cannabis in amorphous form
AU2022315867A1 (en) 2021-07-22 2024-01-25 Nicoventures Trading Limited Compositions comprising a constituent, derivative or extract of cannabis
WO2023002198A1 (en) 2021-07-22 2023-01-26 Nicoventures Trading Limited Compositions comprising a constituent, derivative or extract of cannabis
WO2023002195A1 (en) 2021-07-22 2023-01-26 Nicoventures Trading Limited Methods of preparing compositions comprising a constituent, derivative or extract of cannabis
CA3224601A1 (en) 2021-07-22 2023-01-26 Steven Alderman Constituent, derivative or extract of cannabis in a water soluble matrix
AU2022315589A1 (en) 2021-07-22 2024-01-18 Nicoventures Trading Limited Compositions comprising constituents, derivatives or extracts of cannabis
WO2023053060A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral gum composition
US20230148652A1 (en) 2021-11-15 2023-05-18 Nicoventures Trading Limited Oral products with nicotine-polymer complex
US20230148660A1 (en) 2021-11-15 2023-05-18 Nicoventures Trading Limited Products with enhanced sensory characteristics
CN114304712A (zh) * 2021-12-17 2022-04-12 深圳市元雾科技有限公司 一种液体高负载的尼古丁口含制品颗粒及其制备方法
WO2023119134A1 (en) 2021-12-20 2023-06-29 Nicoventures Trading Limited Substrate material comprising beads for aerosol delivery devices
CN114304711A (zh) * 2021-12-20 2022-04-12 深圳市元雾科技有限公司 一种pH稳定的尼古丁口含制品
CN114521669A (zh) * 2022-02-25 2022-05-24 深圳市元雾科技有限公司 一种尼古丁稳定的口含烟制品及其制备方法
US20230309603A1 (en) 2022-03-31 2023-10-05 R.J. Reynolds Tobacco Company Agglomerated botanical material for oral products
WO2023194959A1 (en) 2022-04-06 2023-10-12 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2024069544A1 (en) 2022-09-30 2024-04-04 Nicoventures Trading Limited Reconstituted tobacco substrate for aerosol delivery device
WO2024069542A1 (en) 2022-09-30 2024-04-04 R. J. Reynolds Tobacco Company Method for forming reconstituted tobacco
WO2024079722A1 (en) 2022-10-14 2024-04-18 Nicoventures Trading Limited Capsule-containing pouched products

Family Cites Families (276)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US865026A (en) 1906-12-15 1907-09-03 Ellis Foster Co Masticable tobacco preparation.
US940521A (en) 1909-05-06 1909-11-16 George A Endicott Wire-stretching appliance.
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3877468A (en) 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3777029A (en) 1971-01-28 1973-12-04 Hoffmann La Roche Chewable multivitamin tablets contain-ing aluminum nicotinate
CH542002A (it) 1971-07-27 1973-09-30 Coster Tecnologie Speciali Spa Contenitore di aerosol su cui è applicato un cappuccio erogatore munito di cannula oscillabile
US3845217A (en) 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
JPS5350515Y2 (da) 1975-02-28 1978-12-04
DE2526702A1 (de) 1975-06-14 1976-12-23 Volkswagenwerk Ag Spruehduese, insbesondere zur hohlraumkonservierung
GB1528391A (en) 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
JPS52114010A (en) 1976-03-22 1977-09-24 Ozawa Miyo Medicine for nicotinism
GB2030862A (en) 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
FR2467604A1 (fr) 1979-10-22 1981-04-30 Mercier Jean Embout adapte pour pulverisation nasale physiologique
US4317837A (en) * 1980-11-25 1982-03-02 Life Savers, Inc. Tobacco-flavored chewing gum
CH658594A5 (de) 1982-02-22 1986-11-28 Bruss Ni Sanitarno Gigieniches Arzneipraeparat mit antinikotinwirkung und verfahren fuer seine herstellung.
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
DE3241437A1 (de) 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
SU1232260A1 (ru) 1983-02-01 1986-05-23 Mamchur Fedor Способ получени вещества,обладающего антиникотиновой активностью
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
US4593572A (en) 1983-10-03 1986-06-10 Universal Thread Grinding Company Lubricated drive mechanism
US4655231A (en) 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
SU1268141A1 (ru) 1984-03-26 1986-11-07 Научно-Производственное Объединение Министерства Пищевой Промышленности Армсср Способ получени антиникотиновой жевательной резинки
DE3429389C1 (de) 1984-08-09 1986-03-13 Brugger, Inge, geb. Ritzau, 8130 Starnberg Inhalator
JPS61251619A (ja) * 1985-04-30 1986-11-08 Nitto Electric Ind Co Ltd ニコチン含有テ−プ製剤
US4800903A (en) * 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
EP0205133A1 (de) 1985-06-14 1986-12-17 Marie Luise Dr. Schicht Plastische Kaumasse auf Basis einer Kaugummigrundmasse
US4817640A (en) 1985-09-19 1989-04-04 Better Life International Life, Inc. Herbal chew and snuff compositions
US4696315A (en) 1985-09-19 1987-09-29 Better Life International, Inc. Herbal snuff composition
JP2543683B2 (ja) 1985-12-13 1996-10-16 武田薬品工業株式会社 綜合ビタミン糖衣錠
US5198226A (en) 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
GB8614805D0 (en) 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
DE3645036A1 (de) 1986-11-18 1989-01-05 Forschungsgesellschaft Rauchen Nikotinhaltiges mittel
FR2608156B1 (fr) 1986-12-12 1988-12-30 Ethypharm Sa Chewing-gum pour se liberer du tabac
US4835162A (en) 1987-02-12 1989-05-30 Abood Leo G Agonists and antagonists to nicotine as smoking deterents
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4933188B1 (en) 1987-12-31 1997-07-15 Warner Lambert Co Chewing gum composition with improved physical stability
JPH01243945A (ja) 1988-03-25 1989-09-28 Lotte Co Ltd 嫌煙ガム
JPH0272118A (ja) 1988-09-08 1990-03-12 Kitsuen Kagaku Kenkyu Zaidan 冠血管拡張剤
GB8828468D0 (en) * 1988-12-06 1989-01-05 Stoppers Co Ltd Nicotine containing lozenge
IE62662B1 (en) 1989-01-06 1995-02-22 Elan Corp Plc Use of nicotine in the treatment of conditions susceptible to said treatment
US5154927A (en) 1989-01-19 1992-10-13 Wm. Wrigley Jr. Company Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
NO168921C (no) 1989-07-31 1992-04-22 Svein Knudsen Roekfri sigaretterstatning til bruk ved roekavvenning ellertil bruk i roekfrie miljoeer
ES2097155T3 (es) 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
US4967733A (en) 1989-10-16 1990-11-06 Rousseau Yvon J Lifting carriage
US5525351A (en) 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
DK615689A (da) 1989-11-07 1991-05-08 Anders Dam Rygesupplement eller rygeerstatningsprodukt
JP2914690B2 (ja) * 1989-12-13 1999-07-05 グレラン製薬株式会社 安定なビタミンｄ▲下３▼類含有製剤
US5512306A (en) 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
US5077104A (en) 1989-12-21 1991-12-31 Alza Corporation Nicotine packaging materials
SE8904295D0 (sv) 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
JPH03209326A (ja) * 1990-01-11 1991-09-12 Teikoku Seiyaku Kk ニコチン含有口腔粘膜貼付剤
JPH03209327A (ja) * 1990-01-11 1991-09-12 Teikoku Seiyaku Kk ニコチン含有口腔粘膜貼付剤
US4996315A (en) * 1990-01-16 1991-02-26 Texaco Chemical Company Novel synthesis of cyclic compounds
US5167242A (en) 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
FI913526A (fi) 1990-08-23 1992-02-24 Wrigley W M Jun Co Tuggummi med laog fukthalt.
US5488962A (en) 1990-10-10 1996-02-06 Perfetti, S.P.A. Chewing gum which is a substitute for tobacco smoke
US5346589A (en) * 1991-02-21 1994-09-13 Genencor International, Inc. Crystalline cellulose production
US5135753A (en) 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
GB9111224D0 (en) 1991-05-24 1991-07-17 Charwell Consumer Prod Smoking substitute preparation
RU2029474C1 (ru) 1991-06-28 1995-02-27 Тетюшева Светлана Игоревна Жевательная резинка
US5326570A (en) 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
GB9200047D0 (en) 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
JP3661131B2 (ja) 1992-02-20 2005-06-15 アスペン ファーマケア ヨーロッパ リミテッド 喫煙抑制具
US5654003A (en) 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
FR2688400B1 (fr) 1992-03-11 1999-06-25 Gilles Gagnot Dispositif pour le lavage de poches parodontales d'un patient.
CA2095776C (en) 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
FR2698268B1 (fr) 1992-11-24 1995-01-20 Oreal Composition photoprotectrice administrée par voie orale.
CN1034551C (zh) 1993-01-01 1997-04-16 丘波岭 烟酸和/或烟酸衍生物在制备戒烟用组合物中的应用
DE4301782C1 (de) 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
US5573774A (en) 1993-02-02 1996-11-12 Keenan; Robert M. Nicotine metabolites, nicotine dependence and human body weight
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5318523A (en) 1993-07-13 1994-06-07 Lu Jieh Shan Drug-feeder for children
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
CN1089834A (zh) 1993-10-14 1994-07-27 王子芸 戒烟口胶的配方及加工工艺
SE9303574D0 (sv) 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
SE502268C2 (sv) 1994-01-26 1995-09-25 Aga Ab Sätt, användning och beredning av aerosol för läkemedelsdistribution innehållande helium och/eller neon
GB2289204B (en) 1994-04-21 1998-01-14 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
WO1996000072A1 (en) 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
IT1274034B (it) 1994-07-26 1997-07-14 Applied Pharma Res Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
US5507278A (en) 1994-11-18 1996-04-16 Karell; Manuel L. Tongue-guard for inhaler
US5810018A (en) 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
ES2175073T3 (es) * 1995-02-08 2002-11-16 Yamanouchi Europ Bv Procedimiento de preparacion de formas para la administracion oral de antibioticos beta-lactamicos de rapida dispersabilidad en agua.
DE69635007T2 (de) 1995-05-11 2006-06-01 University Of Utah Research Foundation, Salt Lake City Tabakersatz
EP0837862A1 (en) 1995-07-05 1998-04-29 The Procter & Gamble Company Warming compounds
US6506425B2 (en) 1995-09-13 2003-01-14 Pharmacia Ab Packaged markable ingestible compressible object
SE9503154D0 (sv) 1995-09-13 1995-09-13 Pharmacia Ab Method for marking objects and objects being marked with such method
US5875774A (en) 1996-01-05 1999-03-02 Sunrise Medical Hhg Inc. Nebulizer
US5692493A (en) 1996-03-08 1997-12-02 Diemolding Corporation Tongue Protector
US5955098A (en) 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
WO1997038679A2 (en) 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
PL187242B1 (pl) 1996-05-13 2004-06-30 Novartis Consumer Health Sa Policzkowy układ dostarczający
TW506836B (en) 1996-06-14 2002-10-21 Janssen Pharmaceutica Nv Fast-dissolving galanthamine hydrobromide tablet
EP0922464B1 (en) 1996-07-12 2005-03-30 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
US5667838A (en) 1996-09-05 1997-09-16 The Procter & Gamble Company Separately milling nut solids and particulate water soluble solids to reduce stickiness and improve flavor intensity of nut spreads
DE19639343C2 (de) 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB2318737B (en) 1996-10-30 2000-06-14 Bespak Plc Improved inhalers
JPH10287561A (ja) * 1997-04-11 1998-10-27 Taisho Pharmaceut Co Ltd イブプロフェン配合固形製剤及びその製造方法
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
CN1089834C (zh) 1997-06-27 2002-08-28 南京英达机械制造有限公司 沥青路面加热再生修补设备
SE9703458D0 (sv) 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
US6908631B1 (en) 1997-12-01 2005-06-21 Nicogen, Inc. Therapeutic and diagnostic methods dependent on CYP2A enzymes
US6265541B1 (en) 1997-12-31 2001-07-24 University Of Utah Research Foundation Uses of α-conotoxin peptides
DE29800300U1 (de) 1998-01-09 1998-04-23 Wieninger Dieter Dr Nikotin und dessen Derivate in Kombination mit einem Antitussivum
KR20010034758A (ko) 1998-04-09 2001-04-25 로렌스 티. 마이젠헬더 신경 장애의 신규 치료 방법
US6211194B1 (en) * 1998-04-30 2001-04-03 Duke University Solution containing nicotine
WO1999063969A1 (en) 1998-06-08 1999-12-16 Groenewoud Pieter J Stabilized thyroxine medications
WO1999065550A1 (en) 1998-06-15 1999-12-23 Karl Holm Inhalation device
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US20020098264A1 (en) 1998-11-27 2002-07-25 Cherukuri Subraman R. Medicated chewing gum delivery system for nicotine
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
AU6412299A (en) 1998-10-08 2000-04-26 Biovail Technologies Limited Composition and method for medicated chewing gum delivery system
JP2000128776A (ja) * 1998-10-19 2000-05-09 Asahi Chem Ind Co Ltd フィルムコーティング顆粒およびその製造方法
WO2000027393A1 (fr) * 1998-11-06 2000-05-18 Fuji Chemical Industry Co., Ltd. Poudres contenant des trocotrienols, procede de production de ces poudres et comprimes prepares par moulage par compression de ces poudres
US6232082B1 (en) 1998-12-01 2001-05-15 Nabi Hapten-carrier conjugates for treating and preventing nicotine addiction
US6551634B2 (en) 1998-12-09 2003-04-22 Hans Boerge Joergensen Method for production of chewing or bubble gum pieces
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
CN1354624A (zh) * 1998-12-15 2002-06-19 Wm·雷格利Jr·公司 从口香糖中控制释放活性剂
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6734215B2 (en) 1998-12-16 2004-05-11 University Of South Florida Exo-S-mecamylamine formulation and use in treatment
JP2002532393A (ja) 1998-12-16 2002-10-02 ユニヴァーシティー オブ サウス フロリダ エキソ−ｒ−メカミラミン製剤および治療におけるその使用
DK1140105T3 (da) 1998-12-24 2004-02-23 Janssen Pharmaceutica Nv Galantaminpræparat med styret frigivelse
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
NZ513208A (en) 1999-02-05 2003-05-30 Cipla Ltd Topical sprays comprising a film forming composition
US6982089B2 (en) 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
DE69941825D1 (de) 1999-03-22 2010-01-28 Pf Medicament Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US20010016593A1 (en) 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
FR2792200B3 (fr) 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
JP4249847B2 (ja) * 1999-05-31 2009-04-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビタミンｋを含有する口腔内崩壊型錠剤
US20080138398A1 (en) 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US20080138399A1 (en) 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
DE19943491B4 (de) 1999-09-10 2010-04-01 Südzucker AG Mannheim/Ochsenfurt Verbesserte Komprimate
US6322828B1 (en) 1999-09-13 2001-11-27 Deseret Laboratories, Inc. Process for manufacturing a pharmaceutical chewing gum
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
EP1231900A1 (en) 1999-11-23 2002-08-21 The Robert Gordon University Bilayered buccal tablets comprising nicotine
GB0004708D0 (en) 2000-02-28 2000-04-19 Britannia Pharmaceuticals Ltd Restricting reinstatement of drug use
DE10013712A1 (de) 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US20010036943A1 (en) 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
US6607752B2 (en) 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
AU2001283393B2 (en) 2000-08-16 2005-09-22 Pharmacia & Upjohn Company Compounds for the treatment of addictive disorders
DE10044545A1 (de) 2000-09-05 2002-04-04 Roland Bodmeier Retardpartikeldispersion
DE60223659T2 (de) 2001-03-23 2008-10-30 Gumlink A/S Einstufiges verfahren zur herstellung von kaugummi
US6861434B2 (en) 2001-04-26 2005-03-01 Wyeth Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
KR20010078976A (ko) 2001-05-28 2001-08-22 전창호 껌의 조성물
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US6602518B2 (en) 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
US6849624B2 (en) 2001-07-31 2005-02-01 Hoffmann-La Roche Inc. Aromatic and heteroaromatic substituted amides
MXPA04001200A (es) 2001-08-08 2004-05-20 Procter & Gamble Materiales adsorbentes de superficie modificada con actividad mejorada.
US7208186B2 (en) 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
HU227543B1 (en) 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
EP1304048B1 (en) 2001-10-22 2004-09-22 Ivo Pera Composition to reduce or quit smoking addiction
US20030082109A1 (en) 2001-10-30 2003-05-01 Leonard Gorenstein Dextrorotary nicotine for smoking cessation
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US6599901B1 (en) 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
FR2832311B1 (fr) 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
AU2002351008B2 (en) 2001-11-30 2007-07-12 Pfizer Products Inc. Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US20060057207A1 (en) 2001-11-30 2006-03-16 Pfizer Inc Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
CA2468717A1 (en) 2001-11-30 2003-06-05 Pfizer Products Inc. Aryl fused azapolycyclic compounds
DE10163667B4 (de) 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DK1458252T3 (da) 2001-12-21 2008-05-13 Galenica Ab Tobak og/eller tobak i kombination med tobakssubstitutkomposition til anvendelse som snus i den orale kavitet
SE0104388D0 (sv) 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
FR2834212B1 (fr) 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
KR100352030B1 (en) 2002-01-10 2002-09-11 Orion Corp Gum composition for removing nicotine
US20040102440A1 (en) 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
WO2003061399A1 (en) 2002-01-25 2003-07-31 De Abhijit Chewing gum composition and a process for preparing the same
AU2003213140A1 (en) 2002-03-01 2003-10-13 The Board Of Regents Of The University Of Nebraska Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
US20030171408A1 (en) 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
SE0200895D0 (sv) 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition
US6797707B2 (en) 2002-03-29 2004-09-28 University Of Florida Antagonists of RF-amide neuropeptides
EP1350434A1 (en) 2002-04-05 2003-10-08 Gum Base Co. S.p.A. Chewing gum in powder form and method of preparation
US6586449B1 (en) 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
CN1383814A (zh) 2002-05-28 2002-12-11 沈阳东宇工业技术研究院有限公司 口腔速崩片及制备方法
SE0201669D0 (sv) 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
ITMI20021392A1 (it) 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US20040002520A1 (en) 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
AU2003243931A1 (en) 2002-07-02 2004-01-23 Gumlink A/S Compressed resin moderated chewing gum
EA010882B1 (ru) 2002-07-02 2008-12-30 Гумлинк А/С Таблетка ii прессованной жевательной резинки
ES2280557T3 (es) 2002-07-02 2007-09-16 Gumlink A/S Goma de mascar comprimida.
CN1665503A (zh) 2002-07-04 2005-09-07 施瓦茨制药有限公司 杂芳烃甲酰胺作为多巴胺－d3配体用于治疗中枢神经系统疾病的用途
US20040013752A1 (en) 2002-07-05 2004-01-22 Wolfson Philip E. Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances
EP1523334A2 (en) 2002-07-18 2005-04-20 Cytos Biotechnology AG Hapten-carrier conjugates and uses thereof
EP1551393A4 (en) 2002-07-30 2010-06-16 Peter Migaly COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
US8354447B2 (en) 2002-09-10 2013-01-15 The Scripps Research Institute mGLU receptors antagonists for treating disorders associated with mGLU receptors including addiction and depression
US7345092B2 (en) * 2002-09-12 2008-03-18 Summit Vetpharm, Llc High concentration topical insecticides containing pyrethroids
GB2393392A (en) 2002-09-17 2004-03-31 Abhijit De Betel nut and nicotine chewing gum
CA2500022C (en) 2002-09-24 2011-02-22 Gumlink A/S Biodegradable chewing gum comprising at least one high molecular weight biodegradable polymer
JP2006500041A (ja) 2002-09-24 2006-01-05 ガムリンク エー／エス 少なくとも２種類の異なる生分解性ポリマーを含有するチューインガム
ATE407568T1 (de) 2002-09-24 2008-09-15 Gumlink As Kaugummi mit niedrigem feuchtigkeitsgehalt
CN1668206A (zh) 2002-09-24 2005-09-14 古木林科有限公司 改进口香糖成分释放的口香糖
JP2006513238A (ja) 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤
ATE512599T1 (de) 2002-12-19 2011-07-15 Swedish Match North Europe Ab Nichtkaubare tabakzusammensetzung
DK1803444T3 (da) * 2002-12-20 2019-02-25 Niconovum Ab Fremgangsmåde til fremstilling af et nikotinholdigt partikelformigt materiale med en krystallinsk cellulose (især mcc)
CN1511550A (zh) 2002-12-27 2004-07-14 袁冀平 一种降低烟碱的药物制剂及应用
US7361667B2 (en) 2003-01-09 2008-04-22 P2D, Inc. 4′,4″-substituted 3α-(diphenylmethoxy) tropane analogs for treatment of mental disorders
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
CA2514325C (en) 2003-01-24 2013-11-12 Magle Holding Ab A composition material for transmucosal delivery
US20040151771A1 (en) 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
WO2004068965A1 (en) 2003-02-04 2004-08-19 Gumlink A/S Compressed chewing gum tablet
AU2003214016A1 (en) 2003-02-04 2004-08-30 Gumlink A/S Compressed chewing gum tablet
EP1449525A1 (en) 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
EP2316418A3 (en) 2003-02-24 2011-09-21 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US20040224963A1 (en) 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
JP2006528237A (ja) 2003-05-20 2006-12-14 ファイザー・プロダクツ・インク バレニクリンの医薬組成物
WO2005040338A2 (en) 2003-05-21 2005-05-06 The Scripps Research Institute Constrained alkaloid immunogens and antibodies and uses thereof
JP2005025135A (ja) * 2003-07-04 2005-01-27 Showa Electric Wire & Cable Co Ltd 高信頼性光導波路型デバイス
ATE443705T1 (de) 2003-07-21 2009-10-15 Pfizer Prod Inc Nikotin abhängigkeit reduzierende heteroaryl kondensierte azapolycyclische verbindungen
US20050058609A1 (en) 2003-07-22 2005-03-17 Alireza Nazeri Medicated toothpick
WO2005018348A2 (en) 2003-08-11 2005-03-03 William Whalen Chewing tobacco substitute with nicotine
CA2536927A1 (en) 2003-09-05 2005-03-17 Actelion Pharmaceuticals Ltd Guanidine derivatives
KR100526760B1 (ko) 2003-09-05 2005-11-08 김현석 체내 니코틴 분해 효과와 다이옥신의 독성을 감소시키는 효과를 가지는 생약재 추출물의 조성물
DE602004019430D1 (de) 2003-09-08 2009-03-26 Mcneil Ab Nikotinformulierungen und ihre verwendung
AU2003286868A1 (en) 2003-09-15 2005-04-27 Luis Viola Solution for cessation of smoking and method to use
WO2005028484A1 (en) 2003-09-19 2005-03-31 F. Hoffmann-La Roche Ag Thiazolopyridine derivatives as adenosine receptor ligands
JP4317729B2 (ja) 2003-10-01 2009-08-19 ジ・エコ株式会社 禁煙用靴下とその製造方法
US20050123502A1 (en) 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
DK1678172T3 (da) 2003-10-15 2010-04-06 Targacept Inc Azabicykliske forbindelser til lindring af smerte og behandling af sygdomme i centralnervesystemet
US20050100513A1 (en) 2003-11-10 2005-05-12 Watkins Mary B. Homeopathic method and system for treating nicotine addiction
US7816356B2 (en) 2003-11-14 2010-10-19 Daniel Yohannes Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic acetylcholine receptor ligands
WO2005053691A2 (en) 2003-12-02 2005-06-16 Fertin Pharma A/S Nicotine delivery product and method for producing it
TW200522944A (en) 2003-12-23 2005-07-16 Lilly Co Eli CB1 modulator compounds
CN1557177A (zh) 2004-02-05 2004-12-29 高永安 含有维生素、抗氧化营养元素、微量元素的胶姆糖
US20050222270A1 (en) 2004-02-26 2005-10-06 Olney John W Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
IL160753A0 (en) 2004-03-04 2004-08-31 Smoking cessation pacifier
US20050226920A1 (en) 2004-04-13 2005-10-13 Kirk Voelker Method of decreasing nicotine withdrawal symptoms during smoking cessation.
SE0402258D0 (sv) 2004-05-07 2004-09-17 Katarina Saend Portionssnus
CN1960709A (zh) 2004-05-21 2007-05-09 阿尔扎公司 递送多种药物形式的剂型
EA011279B1 (ru) 2004-05-24 2009-02-27 Ф. Хоффманн-Ля Рош Аг (4-метокси-7-морфолин-4-илбензотиазол-2-ил)-амид 4-гидрокси-4-метилпиперидин-1-карбоновой кислоты
WO2005115471A2 (en) 2004-05-27 2005-12-08 Neurocure Ltd. Methods and compositions for treatment of nicotine dependence and dementias
EP1761243B1 (en) 2004-06-29 2009-07-15 Fertin Pharma A/S Tobacco alkaloid releasing chewing gum
US20060062835A1 (en) 2004-07-19 2006-03-23 Smoke Free In 3, Inc. Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements
ATE457986T1 (de) 2004-07-22 2010-03-15 Hoffmann La Roche Benzothiazolderivate
AU2005263499B2 (en) 2004-07-22 2010-11-25 F. Hoffmann-La Roche Ag Substituted benzothiazoles
RU2387647C9 (ru) 2004-08-20 2011-05-27 Таргасепт, Инк. Применение n-арилдиазаспироциклических соединений для лечения зависимостей
WO2006028344A1 (en) 2004-09-09 2006-03-16 Industry-Academic Cooperation Foundation Daegu Haany University A composition comprising the purified essential oil extract and lower alcohol soluble extract isolated from angelica gigas for the prevention and treatment of nicotine addiction and withdrawal symptoms
AR050631A1 (es) 2004-09-09 2006-11-08 Novartis Ag Combinacion de compuestos organicos
EP1804798A4 (en) 2004-10-05 2008-01-23 Merck & Co Inc METHODS OF TREATING AN ABUSE OF A SUBSTANCE OF AN ADDICTION TO THAT SUBSTANCE
DE102004048927A1 (de) 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
BRPI0515932A (pt) 2004-10-15 2008-08-12 Pfizer Prod Inc composições e métodos para distribuição intranasal, bucal, sublingual e pulmonar de vareniclina
CA2589489C (en) 2004-11-30 2014-04-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
JP2008530070A (ja) 2005-02-10 2008-08-07 オレクソ・アクチエボラゲット 薬物の経粘膜投与に有用な新規な医薬組成物
WO2006115202A1 (ja) 2005-04-25 2006-11-02 Fuji Sangyo Co., Ltd. ニコチンの毒性軽減組成物
JP2008540356A (ja) 2005-05-06 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬物乱用の治療方法
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US7629342B2 (en) 2005-06-17 2009-12-08 Bristol-Myers Squibb Company Azabicyclic heterocycles as cannabinoid receptor modulators
WO2007006117A1 (en) 2005-07-13 2007-01-18 Nicogen Inc. Novel cyp2a6 inhibitors
US20070134169A1 (en) 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
EP1998754A2 (en) 2006-03-16 2008-12-10 NicoNovum AB Stable lozenge compositions providing rapid release of nicotine
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20080131508A1 (en) 2006-12-01 2008-06-05 Cephalon, Inc Oral transmucosal nicotine dosage form
US20080286341A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080292683A1 (en) 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
US20090081291A1 (en) 2007-09-26 2009-03-26 Gin Jerry B Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
US20090098192A1 (en) 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
FR2984713B1 (fr) 2011-12-22 2013-12-27 Seb Sa Appareil electrique culinaire et moyens de securite associes

Also Published As

Publication number Publication date
EP1803443A3 (en) 2007-07-18
EP3473251B1 (en) 2023-12-13
EP1803444A2 (en) 2007-07-04
AU2003293987B2 (en) 2010-09-09
DE60313216T2 (de) 2008-01-03
ES2285233T3 (es) 2007-11-16
ATE359075T1 (de) 2007-05-15
EP1803444B1 (en) 2018-10-31
DK1803443T3 (da) 2019-02-25
CN1738621B (zh) 2011-04-27
EP1803443A2 (en) 2007-07-04
EP3473251A1 (en) 2019-04-24
PT1578422E (pt) 2007-06-14
JP4708795B2 (ja) 2011-06-22
EP1803444A3 (en) 2007-07-18
EP1578422B1 (en) 2007-04-11
ES2708551T3 (es) 2019-04-10
SI1578422T1 (sl) 2007-12-31
EP1803443B1 (en) 2018-10-31
NO344367B1 (no) 2019-11-18
US8741348B2 (en) 2014-06-03
NZ540817A (en) 2007-07-27
CY1106477T1 (el) 2012-01-25
ES2708552T3 (es) 2019-04-10
US20140234392A1 (en) 2014-08-21
DK3473251T3 (da) 2024-01-22
US20040191322A1 (en) 2004-09-30
NO20191286A1 (no) 2005-07-06
WO2004056363A3 (en) 2004-10-28
CA2511185A1 (en) 2004-07-08
JP2006511566A (ja) 2006-04-06
CN1738621A (zh) 2006-02-22
FI3473251T3 (fi) 2024-01-09
AU2003293987A1 (en) 2004-07-14
NO20053309L (no) 2005-07-06
KR20050096922A (ko) 2005-10-06
US9629832B2 (en) 2017-04-25
CA2511185C (en) 2012-09-18
EP1578422A2 (en) 2005-09-28
WO2004056363A2 (en) 2004-07-08
DK1803444T3 (da) 2019-02-25
NO346973B1 (en) 2023-03-20
DE60313216D1 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
DK1578422T3 (da) Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
IL172619A (en) Pharmaceutical formulations comprising (a) levothyroxine sodium, (b) micro crystalline cellulose, and (c) pregelatinised starch, use thereof in the manufacture of medicaments for the treatment of thyroid hormone disorders in a mammal and a process for preparing said pharmaceutical formulations
MXPA05010422A (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad.
IL164302A (en) Substituted benzazoles, compositions and use thereof in the manufacture of a medicament for the inhibition of raf kinase activity
HRP20090194T1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
NO2013004I2 (no) Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
TW200514579A (en) Orally dissolving films
DK1414451T3 (da) Opioidagonistformuleringer med frigivelig og sekvenstreret antagonist
PL401469A1 (pl) Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja
IL181281A0 (en) Extended release pellet formulation containing pramipexole of a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
RS50924B (sr) Oralni dozni oblici propiverina ili njegovih farmaceutski prihvatljivih soli sa produženim oslobađanjem aktivne materije
IL181282A0 (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
YU53101A (sh) Tableta sa produženim oslobađanjem gliklazida posle oralne primene
JP2009522376A5 (da)
CO6300956A2 (es) Farmaco antiulcera estable superior en la capacidad de absorcion
EA200001201A2 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
ZA200506992B (en) Fibrate tablet and method for the production thereof
NO20076108L (no) Gelatin-inneholdende topikal sammensetning
ATE451912T1 (de) Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
DK1677777T3 (da) Pellets indeholdende venlafaxin-hydrochlorid
NO20051261L (no) Morfin-6-glukuronidsalt
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
DK1255547T3 (da) Kontrolleret-frigivelsessammensætninger indeholdende opioid-agonist og antagonist